🇺🇸 FDA
Patent

US 11149082

Multispecific antibodies targeting human immunodeficiency virus and methods of using the same

granted A61KA61K47/6841A61P

Quick answer

US patent 11149082 (Multispecific antibodies targeting human immunodeficiency virus and methods of using the same) held by The United States of America, As Represented By expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, As Represented By
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K47/6841, A61P, A61P31/18